Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Bile Duct Carcinoma|Advanced Breast Carcinoma|Advanced Cervical Carcinoma|Advanced Endometrial Carcinoma|Advanced Esophageal Carcinoma|Advanced Gastric Carcinoma|Advanced Head and Neck Carcinoma|Advanced Lung Non-Small Cell Carcinoma|Advanced Lung Small Cell Carcinoma|Advanced Malignant Solid Neoplasm|Advanced Ovarian Carcinoma|Advanced Penile Carcinoma|Advanced Pleural Malignant Mesothelioma|Advanced Urothelial Carcinoma|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Clinical Stage III Gastric Cancer AJCC v8|Clinical Stage IV Gastric Cancer AJCC v8|Stage III Cervical Cancer AJCC v8|Stage III Distal Bile Duct Cancer AJCC v8|Stage III Intrahepatic Bile Duct Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Ovarian Cancer AJCC v8|Stage III Penile Cancer AJCC v8|Stage III Pleural Malignant Mesothelioma AJCC v8|Stage IV Cervical Cancer AJCC v8|Stage IV Distal Bile Duct Cancer AJCC v8|Stage IV Intrahepatic Bile Duct Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Penile Cancer AJCC v8|Stage IV Pleural Malignant Mesothelioma AJCC v8|Triple-Negative Breast Carcinoma|Unresectable Urothelial Carcinoma
Interventions: DRUG: Cisplatin|DRUG: Elimusertib|DRUG: Gemcitabine Hydrochloride
Sponsor: National Cancer Institute (NCI)